{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T03:00:43Z","timestamp":1780282843535,"version":"3.54.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jtct.2025.02.026","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T12:56:19Z","timestamp":1741265779000},"page":"386.e1-386.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcome of UCBT for Children With CAEBV: A Retrospective Analysis of a Single Center"],"prefix":"10.1016","volume":"31","author":[{"given":"Zhiyu","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8426-1467","authenticated-orcid":false,"given":"Dao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2025.02.026_bib0001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1182\/blood.2023022739","article-title":"EBV-infected hematopoietic stem cells drive CAEBV","volume":"143","author":"Khanna","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.02.026_bib0002","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3389\/fimmu.2017.01867","article-title":"Chronic active Epstein\u2013Barr virus disease","volume":"8","author":"Kimura","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2025.02.026_bib0003","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fped.2019.00014","article-title":"Advances in the study of chronic active Epstein-Barr virus infection: clinical features under the 2016 WHO Classification and Mechanisms of Development","volume":"7","author":"Arai","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jtct.2025.02.026_bib0004","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/blood-2018-03-785931","article-title":"How I treat T-cell chronic active Epstein-Barr virus disease","volume":"131","author":"Bollard","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.02.026_bib0005","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12185-017-2192-6","article-title":"How we treat chronic active Epstein\u2013Barr virus infection","volume":"105","author":"Sawada","year":"2017","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2025.02.026_bib0006","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood-2013-02-453175","article-title":"Umbilical cord blood transplantation: the first 25 years and beyond","volume":"122","author":"Ballen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.02.026_bib0007","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1002\/sctm.20-0495","article-title":"Umbilical cord blood transplantation: still growing and improving","volume":"10","author":"Zhu","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jtct.2025.02.026_bib0008","doi-asserted-by":"crossref","first-page":"24","DOI":"10.17116\/patol20238504124","article-title":"WHO classification of tumors of hematopoietic and lymphoid tissues, 2022 (5th edition): lymphoid tumors","volume":"85","author":"Baram","year":"2023","journal-title":"Arkh patol"},{"key":"10.1016\/j.jtct.2025.02.026_bib0009","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2025.02.026_bib0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group Report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.02.026_bib0011","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.02.026_bib0012","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.med.57.051804.123642","article-title":"Umbilical cord blood transplantation and banking","volume":"57","author":"Brunstein","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jtct.2025.02.026_bib0013","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jtct.2021.03.012","article-title":"Guidelines for the prevention and management of graft-versus-host disease after cord blood transplantation","volume":"27","author":"Ponce","year":"2021","journal-title":"Transplantation Cell Ther"},{"key":"10.1016\/j.jtct.2025.02.026_bib0014","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1056\/NEJMe2204651","article-title":"Transplantation tolerance through hematopoietic chimerism","volume":"386","author":"Spitzer","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2025.02.026_bib0015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/bmt.2011.140","article-title":"Reduced-intensity conditioning hematopoietic SCT for pediatric patients with LAD-1: clinical efficacy and importance of chimerism","volume":"47","author":"Hamidieh","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.02.026_bib0016","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.bmt.1703796","article-title":"Unrelated bone marrow transplantation for Epstein\u2013Barr virus-associated T\/NK-cell lymphoproliferative disease","volume":"31","author":"Okamura","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.02.026_bib0017","doi-asserted-by":"crossref","first-page":"e2328","DOI":"10.1002\/rmv.2328","article-title":"EBV associated T- and NK-cell lymphoproliferative diseases: a comprehensive overview of clinical manifestations and novel therapeutic insights","volume":"32","author":"Shafiee","year":"2022","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jtct.2025.02.026_bib0018","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK\u2013cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.02.026_bib0019","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ajh.21247","article-title":"Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disease in Japan","volume":"83","author":"Sato","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2025.02.026_bib0020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12519-021-00470-9","article-title":"Haploidentical hematopoietic stem cell transplantation for pediatric patients with chronic active Epstein\u2013Barr virus infection: a retrospective analysis of a single center","volume":"17","author":"Luo","year":"2021","journal-title":"World J Pediatr"},{"issue":"11","key":"10.1016\/j.jtct.2025.02.026_bib0021","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.3390\/cancers12113202","article-title":"Chronic active Epstein-Barr virus infection: is it immunodeficiency, malignancy, or both?","volume":"12","author":"Fujiwara","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jtct.2025.02.026_bib0022","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bjh.16107","article-title":"Current status of umbilical cord blood transplantation in children","volume":"190","author":"Gabelli","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2025.02.026_bib0023","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbmt.2013.10.026","article-title":"Umbilical cord blood as an alternative source of reduced-intensity hematopoietic stem cell transplantation for chronic Epstein-Barr virus\u2013associated t or natural killer cell lymphoproliferative diseases","volume":"20","author":"Sawada","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.02.026_bib0024","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fped.2018.00334","article-title":"Hematopoietic stem cell transplantation for the treatment of Epstein-Barr virus-associated T- or NK-Cell lymphoproliferative diseases and associated disorders","volume":"6","author":"Sawada","year":"2018","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.jtct.2025.02.026_bib0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13023-021-01909-y","article-title":"Outcome of L-DEP regimen for treatment of pediatric chronic active Epstein-Barr virus infection","volume":"16","author":"Ma","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtct.2025.02.026_bib0026","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood.V97.10.2962","article-title":"Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia","volume":"97","author":"Rocha","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.02.026_bib0027","first-page":"1331","article-title":"Hematopoietic cell transplantation for chronic active EBV infection","volume":"9","author":"Inoue","year":"2019","journal-title":"Rinsho ketsueki"},{"key":"10.1016\/j.jtct.2025.02.026_bib0028","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/bmt.2010.122","article-title":"Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection","volume":"46","author":"Kawa","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.02.026_bib0029","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ajh.24933","article-title":"Improved prognosis with additional medium-dose VP16 to CY\/TBI in allogeneic transplantation for high risk ALL in adults","volume":"93","author":"Arai","year":"2017","journal-title":"American J Hematol"},{"key":"10.1016\/j.jtct.2025.02.026_bib0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41409-024-02212-7","article-title":"Sequential haplo-identical conditioning transplant regimen for pediatric patients with relapsed or refractory hemophagocytic lymphohistiocytosis","volume":"59","author":"Yue","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.02.026_bib0031","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2141.2009.07782.x","article-title":"Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications","volume":"147","author":"Delaney","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2025.02.026_bib0032","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/blood-2013-05-502385","article-title":"Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome","volume":"123","author":"Lindemans","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.02.026_bib0033","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1470-2045(15)00462-3","article-title":"Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial","volume":"17","author":"Walker","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtct.2025.02.026_bib0034","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1506002","article-title":"Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease","volume":"374","author":"Kr\u00f6ger","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2025.02.026_bib0035","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-019-1393-7","article-title":"Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study","volume":"17","author":"Lin","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.jtct.2025.02.026_bib0036","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1182\/blood-2014-09-599241","article-title":"Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation","volume":"126","author":"Pascal","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2025.02.026_bib0037","doi-asserted-by":"crossref","first-page":"e2108","DOI":"10.1002\/rmv.2108","article-title":"Epstein-Barr virus related post-transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Lindsay","year":"2020","journal-title":"Rev Med Virol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725010632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725010632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T02:11:55Z","timestamp":1780279915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725010632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2666636725010632"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.02.026","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcome of UCBT for Children With CAEBV: A Retrospective Analysis of a Single Center","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}